These 2 Under-the-Radar Stocks Could Be Key to Coronavirus Vaccine Distribution
With 11 coronavirus vaccine candidates in phase 3 clinical trials and six already cleared for limited use, the focus on trial results will soon give way to logistical concerns. As vaccines are authorized by regulatory agencies like the Food and Drug Administration, plans will kick into gear to get hundreds of thousands -- even millions -- of doses of each vaccine distributed around the globe. While governments have pumped billions of dollars into vaccine development and manufacturing, the bottleneck in supplying the world with these COVID-19 preventatives will rest on companies that have rarely been mentioned so far during the pandemic.
News about familiar names like Moderna, Pfizer, and Johnson & Johnson will give way as the makers of specialty glass vials and test tubes, such as West Pharmaceutical Services (NYSE: WST), and vaccine refrigerators, like Thermo Fisher Scientific (NYSE: TMO), try to ramp up production to meet demand. Dr. Rick Bright, who was leading the Biomedical Advanced Research and Development Authority (BARDA), warned in a May whistleblower complaint that it could take two years for the U.S. to procure enough vials to vaccinate Americans. This projection doesn't even account for additional requirements to support annual dosing. Even when enough containers do exist, nearly 3 billion people in the world live in areas where temperature-controlled storage is lacking.
Image source: Getty Images
Source Fool.com
